Recombinant multi-species G3BP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G3BP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes one of the DNA-unwinding enzymes which prefers partially unwound 3'-tailed substrates and can also unwind partial RNA/DNA and RNA/RNA duplexes in an ATP-dependent fashion. This enzyme is a member of the heterogeneous nuclear RNA-binding proteins and is also an element of the Ras signal transduction pathway. It binds specifically to the Ras-GTPase-activating protein by associating with its SH3 domain. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
The Alternative Names of target: ATP-dependent DNA helicase VIII (hDH VIII),B430204O07,G3BP,G3BP-1,G3BP1,G3bp,G3bp1,GAP SH3 domain-binding protein 1,HDH-VIII,RGD1310666,Ras GTPase-activating protein-binding protein 1,mKIAA4115

Target products collectionGo to G3BP1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T16886-Ag-1/ GM-Tg-hg-T16886-Ag-2 Human G3BP1 protein Human
GM-Tg-rg-T16886-Ag-1/ GM-Tg-rg-T16886-Ag-2 Rat G3BP1 protein Rat
GM-Tg-mg-T16886-Ag-1/ GM-Tg-mg-T16886-Ag-2 Mouse G3BP1 protein Mouse
GM-Tg-cynog-T16886-Ag-1/ GM-Tg-cynog-T16886-Ag-2 Cynomolgus/Rhesus macaque G3BP1 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T16886-Ag-1/ GM-Tg-felg-T16886-Ag-2 Feline G3BP1 protein Feline
GM-Tg-cang-T16886-Ag-1/ GM-Tg-cang-T16886-Ag-2 Canine G3BP1 protein Canine
GM-Tg-bovg-T16886-Ag-1/ GM-Tg-bovg-T16886-Ag-2 Bovine G3BP1 protein Bovine
GM-Tg-equg-T16886-Ag-1/ GM-Tg-equg-T16886-Ag-2 Equine G3BP1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T16886-Ag-1/ GM-Tg-hg-T16886-Ag-2; GM-Tg-rg-T16886-Ag-1/ GM-Tg-rg-T16886-Ag-2;
GM-Tg-mg-T16886-Ag-1/ GM-Tg-mg-T16886-Ag-2; GM-Tg-cynog-T16886-Ag-1/ GM-Tg-cynog-T16886-Ag-2;
GM-Tg-felg-T16886-Ag-1/ GM-Tg-felg-T16886-Ag-2; GM-Tg-cang-T16886-Ag-1/ GM-Tg-cang-T16886-Ag-2;
GM-Tg-bovg-T16886-Ag-1/ GM-Tg-bovg-T16886-Ag-2; GM-Tg-equg-T16886-Ag-1/ GM-Tg-equg-T16886-Ag-2
Products Name G3BP1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name G3BP1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine G3BP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.